MLEC

Moolec Science SA

1.40

Oct 30 • 3:59 PM ET +0.03 (2.19%)

1.42

Aftermarket • 7:36 PM ET +0.02 (1.43%)

Healthcare Biotechnology Cayman Islands Nano NASD

Peers: EVGN CBUS CLGN DYAI DNA CDXS IBIO LEXX ICCC BIOX

Scroll to Statements

Index	-
Market Cap	1.02M
Enterprise Value	72.38M
Income	-
Sales	-
Book/sh	12.70
Cash/sh	1.48
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Mar 02, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.11
P/C	0.94
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.08
Current Ratio	0.15
Debt/Eq	7.21
LT Debt/Eq	1.30
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	-583.54% -583.54%
Sales past 3/5Y	- -
EPS Y/Y TTM	-24.98%
Sales Y/Y TTM	-
EPS Q/Q	-32.08%
Sales Q/Q	948.32%
Earnings	-
EPS/Sales Surpr.	-16.67% 29.32%

Insider Own	72.45%
Insider Trans	0.00%
Inst Own	0.07%
Inst Trans	-
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-38.18%
SMA50	-70.20%
SMA200	-80.64%
Trades

Shs Outstand	0.27M
Shs Float	0.20M
Short Float	2.79%
Short Ratio	0.14
Short Interest	0.01M
52W High	23.22 -93.97%
52W Low	1.34 4.48%
Volatility	13.50% 23.42%
ATR (14)	0.42
RSI (14)	20.74
Beta	0.31
Rel Volume	0.19
Avg Volume	38.49K
Volume	7,257

Perf Week	-18.60%
Perf Month	-70.89%
Perf Quarter	-79.91%
Perf Half Y	-86.50%
Perf YTD	-63.34%
Perf Year	-84.45%
Perf 3Y	-99.66%
Perf 5Y	-99.91%
Perf 10Y	-
Recom	1.00
Target Price	450.00
Prev Close	1.37
Price	1.40
Change %	2.19%

Consensus

Strong Buy

Avg. Price Target

$450.00

Implied Upside

+32,042.9%

Analysts1incl. previous ratings

Rating Distribution1 Buy · 0 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Sep 27, 2023	Initiated	RROTH MKM	Buy	$5	+257.1%

May-14-26 09:00AM	Moolec Science Successfully Completes 2026 GLASO Commercial Planting Campaign in the United States (ACCESSWIRE)
May-13-26 06:35PM	Moolec Science SA Regains Compliance with All Nasdaq Capital Market Continued Listing Requirements Within Panel Remediation Period (ACCESSWIRE) -5.12%
Apr-29-26 09:03AM	Moolec Science Confirms Completion of First Phase of GLASO Industrialization Following Record 2025 Campaign; Advances 2026 Sowing and Expands Into Energy Applications (ACCESSWIRE)
Apr-07-26 08:00AM	Moolec Science Announces Breakthrough in Molecular Farming With Successful Expression of Bovine Myoglobin in Pea Seeds (ACCESSWIRE)
Feb-13-26 10:11AM	Moolec Science (MLEC) Stock Explodes 90% After GLA Update (Benzinga) +69.22%
08:00AM	Loading…
08:00AM	Moolec Science Achieves One of the Highest Commercial-Scale GLA Concentrations From U.S. GLASO1 Crushing (ACCESSWIRE)
Jan-30-26 04:20PM	Moolec Science Granted Continued Listing on Nasdaq Subject to Hearings Panel Conditions (ACCESSWIRE) -17.38%
Jan-23-26 06:30PM	Moolec Science S.A. Receives Nasdaq Staff Memo Supporting Panel Exception Through June 29, 2026 to Regain Compliance with Stockholders' Equity Requirement (ACCESSWIRE) +10.62% -5.07%
Jan-22-26 09:20AM	Moolec Science S.A. Receives Nasdaq Panel Exception Through June 29, 2026 to Regain Compliance with Stockholders' Equity Requirement (ACCESSWIRE)
Jan-05-26 09:00PM	Moolec Science Announces Effectiveness of Share Consolidation (ACCESSWIRE) -11.63%
Dec-31-25 06:00PM	Moolec Receives Staff Determination Letter and Provides Update on Nasdaq Listing Compliance Status (ACCESSWIRE) +8.41%
09:00AM	Moolec Science SA Announces the Implementation of a Share Consolidation of Its Ordinary Shares, Par Value U.S.$0.10 Per Share (the "Shares") (ACCESSWIRE)
Dec-11-25 08:00AM	Moolec Science Scales GLASO U.S. Platform With Record 2025 Campaign and Expansion Into Nutrition & Supplements Market (ACCESSWIRE) -6.67%
Nov-28-25 01:15PM	Moolec Receives Nasdaq Determination Letter (ACCESSWIRE)
Nov-21-25 05:37PM	Moolec Receives Nasdaq Determination Letter (ACCESSWIRE)
07:00AM	Loading…
Sep-11-25 07:00AM	Moolec Science Secures Regulatory Approval for Safflower GLASO Technology in Argentina, Expands U.S. Acreage, and Strengthens Leadership With CFO Appointment (ACCESSWIRE) +11.29%
Jun-18-25 07:00AM	Moolec Science Secures Core U.S. Patent for Piggy Sooy(TM), Soybean Expressing Up to 30% of Animal Protein (ACCESSWIRE) +14.83%
Jun-17-25 07:00AM	Moolec Science Announces Successful Closing of Business Combination, Expanding Across Life Sciences and Food-Tech (ACCESSWIRE)
Jun-11-25 07:00AM	Moolec Science Regains NASDAQ Compliance (ACCESSWIRE)
May-12-25 07:00AM	Moolec Science Announces Effectiveness of Reverse Stock Split (ACCESSWIRE)
Apr-21-25 07:00AM	Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms (ACCESSWIRE)
Mar-17-25 05:00PM	Moolec Received Nasdaq Staff Determination Letter (ACCESSWIRE) -10.00%
Oct-17-24 07:00AM	Biotech Wants Vegetarians to Eat Its Peas Spliced With Beef DNA (Bloomberg)
Oct-16-24 06:00AM	Moolec Has Received USDA Approval for the First Genetically Modified Pea in History (ACCESSWIRE)
Oct-02-24 06:00AM	Moolec Science Presents Fiscal Year 2024 Annual Business Update (ACCESSWIRE) +5.88%
Oct-01-24 09:00AM	Moolec Science SA (MLEC) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Sep-25-24 06:00AM	Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call (ACCESSWIRE)
Sep-13-24 06:30PM	Moolec Received NASDAQ Bid Price Letter (ACCESSWIRE)
Sep-05-24 06:00AM	Moolec Confirms US Harvest and Promising Yields for Plant-Grown Products GLASO(TM) and Piggy Sooy(TM) in October (ACCESSWIRE) -8.15%
Jul-15-24 10:10AM	SolarEdge Layoffs 2024: What to Know About the Latest Solar Job Cuts (InvestorPlace) -12.75%
08:33AM	Loading…
08:33AM	Why Is Moolec Science (MLEC) Stock Down 18% Today? (InvestorPlace)
07:35AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
06:00AM	Moolec Signs an Offtake Agreement With Major Global CPG Company to Hit the US Market in 2025 (ACCESSWIRE)
May-30-24 01:52PM	MLEC Stock Earnings: Moolec Science Beats EPS for Q3 2024 (InvestorPlace)
06:00AM	Moolec Science Presents Third Quarter Fiscal Year 2024 Business Update (ACCESSWIRE)
May-23-24 07:00AM	Moolec Science to Host Third Quarter Fiscal Year 2024 Business Update Conference Call (ACCESSWIRE)
Apr-30-24 06:00AM	Moolec Announces New Patent Granting in the United States for Molecular Farming Platform (ACCESSWIRE)
Apr-22-24 08:01AM	Why Is Moolec Science (MLEC) Stock Up 121% Today? (InvestorPlace) +76.43%
06:00AM	Moolec Becomes First Molecular Farming Company to Achieve USDA Approval for Plant-Grown Animal Proteins (ACCESSWIRE)
Mar-13-24 06:30AM	Moolec Science Presents Second Quarter Fiscal Year 2024 Business Update (ACCESSWIRE)
Mar-06-24 08:00AM	Moolec Science to Host Second Quarter Fiscal Year 2024 Business Update Conference Call (ACCESSWIRE)
Jan-11-24 09:35AM	Down -18.03% in 4 Weeks, Here's Why You Should You Buy the Dip in Moolec Science SA (MLEC) (Zacks) +26.50%
08:27AM	Why Is Moolec Science (MLEC) Stock Up 40% Today? (InvestorPlace)
Dec-18-23 11:52AM	MLEC Stock Earnings: Moolec Science Reported Results for Q1 2024 (InvestorPlace) +5.52%
Dec-14-23 06:00AM	Moolec Science Presents First Quarter Fiscal Year 2024 Business Update (ACCESSWIRE)
Dec-07-23 08:00AM	Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference Call (ACCESSWIRE)
Oct-20-23 05:00PM	Moolec Science Presents Fourth Quarter FY 2023 Business Update (ACCESSWIRE) -6.99%
Oct-17-23 05:00PM	Moolec Science to Host Fiscal Year 2023 Business Update Conference Call (ACCESSWIRE) +13.44% -6.68%
08:00AM	Moolec Science Announces Capital Raise With Strategic Investors for ~US $30 Million (ACCESSWIRE)
08:00AM	Moolec Science Announces ~US $30 Million Capital Raise With Strategic Investors (ACCESSWIRE)
Jun-26-23 08:30AM	Moolec Science Presents 'Piggy Sooy', a Soybean Platform That Can Produce Significantly High Amounts of Pork Proteins (ACCESSWIRE) +13.10%
May-30-23 04:30PM	Moolec Science Presents Third Quarter FY 2023 Business Update (ACCESSWIRE)
May-24-23 04:00PM	Moolec Science to Host Third Quarter FY 2023 Business Update Call (ACCESSWIRE) -5.92%
Apr-17-23 10:55PM	Moolec Science Secures Up to $50 Million in Committed Equity Financing With Nomura (ACCESSWIRE) -5.77%
Apr-11-23 08:25AM	Moolec Science Acquires Food Ingredient Capabilities to Consolidate Molecular Farming Technology (ACCESSWIRE)
Apr-05-23 06:00AM	Moolec Science Achieves USDA-APHIS Regulatory Status Review Clearance for Molecular Farming Product (ACCESSWIRE)
Jan-17-23 09:00AM	Moolec Science to Ring Nasdaq Stock Market Closing Bell on January 17, 2023 (GlobeNewswire)
Jan-03-23 08:00AM	Molecular Farming Company Moolec Science Starts Trading on Nasdaq After Successful Closing of Business Combination (GlobeNewswire) -24.79%

Show Previous News

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. It operates through the following segments: Seed and Integrated Products, Crop Protection, Crop Nutrition, and Emerging Solutions. The company was founded by Gaston Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Chief Executive OfficerMr. Alejandro Antalich

Co-Founder & Chief Product OfficerMr. Henk Hoogenkamp Ph.D.

Co-FounderMr. Martin Salinas Ph.D.

Chief Financial OfficerMs. Valeria Falottico

Chief Technology OfficerDr. Paola Diaz Dellavalle

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MLEC

Moolec Science SA

Upgrade your Finviz experience